Review clarifies Survodutide's dual-agonist mechanism and promising clinical performance for obesity and liver disease
How does survodutide work? Plain language review of a potential new medication for obesity and liver disease
Abstract
A plain language review clarifies survodutide's dual-agonist mechanism and promising clinical performance for obesity and liver disease.